Continuation of treatment and monitoring of safety in patients treated with LY353381 [arzoxifene] for advanced cancer
Phase of Trial: Phase IV
Latest Information Update: 06 Jun 2007
At a glance
- Drugs Arzoxifene (Primary)
- Indications Advanced breast cancer; Endometrial cancer; Ovarian cancer
- Focus Adverse reactions
- 06 Jun 2007 Status changed from in progress to completed.
- 16 Oct 2005 New trial record.